Dopar side effects, by duration, gender and age (a phase IV clinical study of FDA data)

female:

1. Blood creatine phosphokinase increased
2. Acute myocardial infarction (acute heart attack)
3. Aminoaciduria (presence of amino acids in the urine)
4. Drug ineffective
5. Peripheral vascular disorder

male:

1. Blood glucose increased
2. Aphasia (damage to the parts of the brain that control language)
3. Blood catecholamines increased
4. Constipation
5. Rectal haemorrhage (bleeding from anus)

0-1:

n/a

2-9:

1. Aminoaciduria (presence of amino acids in the urine)

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

1. Blood creatine phosphokinase increased
2. Acute myocardial infarction (acute heart attack)
3. Blood catecholamines increased
4. Drug ineffective
5. Peripheral vascular disorder
6. Rectal haemorrhage (bleeding from anus)